Most Clicked StoriesMore >


How deep a discount will biosimilars bring to the market?

PCMA SmartBrief | Mar 23, 2015

Biosimilars are expected to bring varying levels of competitive pressure to the prices of existing treatments. Wall Street Journal (tiered subscription model), The (03/22)


Ark. legislators shouldn't interfere with pharmacy reimbursement

PCMA SmartBrief | Mar 20, 2015

N.Y. pharmacist is accused of $5M Medicare, Medicaid fraud

PCMA SmartBrief | Mar 23, 2015

Preferred pharmacy plans in Medicare Part D increasingly popular

PCMA SmartBrief | Mar 24, 2015

PCMA: Pharmacy lock-in plan has wide support

PCMA SmartBrief | Mar 25, 2015

PCSK9 inhibitors are expected to carry a high cost

PCMA SmartBrief | Mar 20, 2015

Judge clears Novartis to market first U.S. biosimilar

PCMA SmartBrief | Mar 20, 2015

Obama to outline new health care cost containment initiative

PCMA SmartBrief | Mar 25, 2015

HHS inspector general calls for CMS action to curtail pharmacy waste

PCMA SmartBrief | Mar 20, 2015

Analysis shows $1B sales potential for Bristol-Myers, Sanofi, Novartis drugs

PCMA SmartBrief | Mar 24, 2015


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more